Please provide your email address to receive an email when new articles are posted on . Corneal cross-linking should be considered as a viable treatment for patients of all ages with keratoconus due ...
Please provide your email address to receive an email when new articles are posted on . Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a joint society of cornea, cataract and ...
SHERBORN, Mass.--(BUSINESS WIRE)--CXL Ophthalmics, Inc., a clinical-stage company developing a minimally-invasive treatment for keratoconus, today published results of the EpiSmart cross-linking Phase ...
While I congratulate the Journal for encouraging such interesting debates and the authors for their hard work in presenting their points of view, I feel it is necessary to point out two inaccuracies ...
"Corneal cross-linking is beneficial to my patients in that if offers them a therapeutic option to limit the progression of keratoconus," says Dr. Mitchel Jackson. "The FDA approval of corneal ...
A study published in Ophthalmology and Therapy found that Epioxa, an epithelium-on corneal collagen cross-linking treatment, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results